Skip to main content

Colgate-Palmolive - Fundamentalanalyse - Jahresbericht / Bilanz / Geschäftsbericht

Colgate-Palmolive (ISIN: US1941621039, WKN: 850667) Kursdatum: 21.07.2017 Kurs: 73,270 USD
Beschreibung Daten
Symbol CL
Marktkapitalisierung 65.825.767.424,00 USD
Land Vereinigte Staaten von Amerika
Indizes S&P 500
Sektor Konsumgüter
Rohdaten nach US GAAP in Millionen USD
Aktiensplits 2013-05-16 - 2:1 | 1999-07-01 - 2:1 | 1997-05-16 - 2:1 |
Internet
Letztes Bilanz Update 23.02.2017

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 21.07.2017
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
25,83 20,96 2,12% 20,16 -2,00 26,94 4,33 -270,89

Firmenbeschreibung

Quarterly Financial Data (Unaudited)  Total FirstQuarter SecondQuarter ThirdQuarter FourthQuarter 2015          Net sales$16,034 $4,070 $4,066 $3,999 $3,899 Gross profit9,399(1) 2,392(3) 2,367(5) 2,347(7) 2,293(9) Net income (loss) including noncontrolling interests1,548(2) 583(4) 616(6) 770(8) (421)(10) Net income (loss) attributable to Colgate-Palmolive Company1,384(2) 542(4) 574(6) 726(8) (458)(10) Earnings (loss) per common share:          Basic1.53(2) 0.60(4) 0.63(6) 0.81(8) (0.51)(10) Diluted1.52(2) 0.59(4) 0.63(6) 0.80(8) (0.51)(10) (21)            2014          Net sales$17,277 $4,325 $4,352 $4,379 $4,221 Gross profit10,109(11) 2,524(13) 2,552(15) 2,558(17) 2,475(19) Net income including noncontrolling interests2,339(12) 432(14) 661(16) 580(18) 666(20) Net income attributable to Colgate-Palmolive Company2,180(12) 388(14) 622(16) 542(18) 628(20) Earnings per common share:          Basic2.38(12) 

Firmenstrategie

Principles of ConsolidationThe Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2015 and 2014, equity method investments included in Other assets in the Consolidated Balance Sheets were $34 and $31, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method. Effective December 31, 2015, the Company began accounting for the operations of its Venezuelan subsidiary (“CP Venezuela”) using the cost method of accounting and as a result its Consolidated Balance Sheet as of December 31, 2015 no longer includes the assets and liabilities of CP Venezuela. See Note 14, Venezuela for further information.

RevenueRecognitionPolicyTextBlock

Revenue Recognition


Sales are recorded at the time products are shipped to trade customers and when risk of ownership transfers. Net sales reflect units shipped at selling list prices reduced by sales returns and the cost of current and continuing promotional programs. Current promotional programs, such as product listing allowances and co-operative advertising arrangements, are recorded in the period incurred. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements with trade customers. The redemption cost of consumer coupons is based on historical redemption experience and is recorded when coupons are distributed. Volume-based incentives offered to trade customers are based on the estimated cost of the program and are recorded as products are sold.

SegmentReportingDisclosureTextBlock

Segment Information


The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.


The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of the operating segment performance because it excludes the impact of corporate-driven decisions related to interest expense and income taxes.


The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock unit awards, research and development costs, Corporate overhead costs, restructuring and related implementation costs, and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments. 


Approximately 75% of the Company’s Net sales are generated from markets outside the U.S., with over 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Wal-Mart Stores, Inc. and its affiliates represent approximately 11% of the Company's Net sales in 2015. No other customer represents more than 10% of Net sales.


In 2015, Corporate Operating profit (loss) includes charges of $1,084 related to the change in accounting for the Company’s Venezuelan operations, $254 related to the 2012 Restructuring Program, $34 related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets as a result of effective devaluations and $14 for a foreign competition law matter and included a gain of $187 on the sale of the Company’s laundry detergent business in the South Pacific. In 2014, Corporate Operating profit (loss) includes charges of $286 related to the 2012 Restructuring Program, $327 related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets as a result of effective devaluations and $41 for foreign competition law matters and costs of $4 related to the sale of land in Mexico. In 2013, Corporate Operating profit (loss) included charges of $371 related to the 2012 Restructuring Program, $172 related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets as a result of a devaluation and $23 for a foreign competition law matter and costs of $18 related to the sale of land in Mexico. For further information regarding the 2012 Restructuring Program, refer to Note 4, Restructuring and Related Implementation Charges. For further information regarding Venezuela, refer to Note 14, Venezuela. For further information regarding the foreign competition law matters, refer to Note 13, Commitments and Contingencies. For further information regarding the sale of land in Mexico and the sale of the Company’s laundry detergent business in the South Pacific, refer to Note 3, Acquisitions and Divestitures.


 
 
2015
 
2014
 
2013
Net sales
 
 
 
 
 
 
Oral, Personal and Home Care
 
 
 
 
 
 
North America(1)
 
$
3,149

 
$
3,124

 
$
3,072

Latin America
 
4,327

 
4,769

 
5,012

Europe/South Pacific
 
2,870

 
3,406

 
3,396

Asia
 
2,478

 
2,515

 
2,472

Africa/Eurasia
 
998

 
1,208

 
1,257

Total Oral, Personal and Home Care
 
13,822

 
15,022

 
15,209

Pet Nutrition(2)
 
2,212

 
2,255

 
2,211

Total Net sales
 
$
16,034

 
$
17,277

 
$
17,420

_________

(1) 
Net sales in the U.S. for Oral, Personal and Home Care were $2,896, $2,835 and $2,771 in 2015, 2014 and 2013, respectively.
(2) 
Net sales in the U.S. for Pet Nutrition were $1,223, $1,149 and $1,116 in 2015, 2014 and 2013, respectively.


EarningsPerSharePolicyTextBlock

Earnings Per Share

 
 
2015
 
2014
 
2013
Operating profit
 
 
 
 
 
 
Oral, Personal and Home Care
 
 

 
 

 
 
North America
 
$
974

 
$
926

 
$
927

Latin America
 
1,209

 
1,279

 
1,385

Europe/South Pacific
 
750

 
877

 
805

Asia
 
753

 
736

 
698

Africa/Eurasia
 
178

 
235

 
268

Total Oral, Personal and Home Care
 
3,864

 
4,053

 
4,083

Pet Nutrition
 
612

 
592

 
563

Corporate
 
(1,687
)
 
(1,088
)
 
For the Year Ended 2015
 
For the Year Ended 2014
 
For the Year Ended 2013
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
Basic EPS
$
1,384

 
902.2

 
$
1.53

 
$
2,180

 
915.1

 
$
2.38

 
$
2,241

 
930.8

 
$
2.41

Stock options and restricted stock units
 
 
7.5

 
 

 
 

 
9.2

 
 

 
 

 
9.1

 
 

Diluted EPS
$
1,384

 
909.7

 
$
1.52

 
$
2,180

 
924.3

 
$
2.36

 
$
2,241

 
939.9

 
$
2.38


Basic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of shares of common stock outstanding for the period.


Diluted earnings per common share is computed using the treasury stock method on the basis of the weighted-average number of shares of common stock plus the dilutive effect of potential common shares outstanding during the period. Dilutive potential common shares include outstanding stock options and restricted stock units.


As of December 31, 2015, 2014 and 2013, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 3,228,359, 1,729,511 and 1,785,032, respectively. As of December 31, 2015, 2014 and 2013, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 120, 2,311 and 3,709, respectively.